The 21 RCCA physicians named to Castle Connolly’s prestigious list of 2022 Top Cancer Doctors in New Jersey are:
May Abdo-Matkiwsky, DO, serving the Sparta community
Kaleen Ahmad, MD, serving the Cape May Court House/Marmora community
Seth Berk, MD, serving the Moorestown community
Andrew Bernstein, DO, serving the Pompton Plains community
Maurice Cairoli, MD, serving the Moorestown community
Jumana Chatiwala, MD, serving the Sparta community
Michele Donato, MD, serving the Hackensack community
Tatyana Feldman, MD, serving the Hackensack community
Denis Fitzgerald, MD, serving the Little Silver community
Glen Gejerman, MD, serving the Hackensack community
Andre Goy, MD, serving the Hackensack community
Harry Harper, MD, serving the Hackensack community
Anthony Ingenito, MD, serving the Hackensack community
Andrew Jennis, MD, serving the Hackensack/North Bergen community
James Lee, MD, serving the Moorestown community
Mark Pascal, MD, serving the Franklin Lakes/Hackensack community
Andrew Pecora, MD, serving the Hackensack/North Bergen community
Scott Rowley, MD, serving the Hackensack community
Ami Vaidya, MD, serving the Hackensack community
Stanley Waintraub, MD, serving the Hackensack community
Stephen Wallace, MD, serving the Moorestown community
Of the more than 850,000 practicing physicians in the U.S., just 7% are named to the Top Doctors list. The designation is conferred only after a rigorous vetting process conducted by an experienced medical review board. Reviewers consider each doctors’ skills, professionalism, training/qualifications, experience, competence, outcomes and achievements as well as his or her relational skills and empathy toward patients.
RCCA has 90-plus cancer specialists who treat patients at more than 25 RCCA care centers in New Jersey, Connecticut, Maryland and the Washington, D.C., area. Those oncologists see more than 23,000 new patients each year and provide care to more than 225,000 established patients, collaborating closely with their patients’ other physicians. They offer patients the latest in cutting-edge treatments, including immunotherapies and targeted therapy, as well as access to a wide range of clinical trials. In addition to serving patients who have solid tumors, blood-based cancers, and benign blood disorders such as anemia, RCCA care centers also provide infusion services to people with a number of non-oncologic conditions—including multiple sclerosis, Crohn’s disease, asthma, and rheumatoid arthritis — who take intravenously-administered medications.
To learn more about RCCA, call 844-928-0089 or visit RCCA.com.